Clinical Trials Logo

Sacroiliitis clinical trials

View clinical trials related to Sacroiliitis.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06053255 Not yet recruiting - Sacroiliitis Clinical Trials

Use of the Neurolyser XR for the Treatment of Low Back Pain Related to Sacroiliitis

Start date: November 15, 2023
Phase: N/A
Study type: Interventional

The Neurolyser XR is a device used to deliver high-intensity focused ultrasound for the ablation of the lateral sacral branch nerve in patients with Sacroiliitis.

NCT ID: NCT06034808 Not yet recruiting - Sacroiliitis Clinical Trials

Frequency of Sacroiliitis in Inflammatory Bowel Disease Patients Using MRI

Start date: November 2023
Phase:
Study type: Observational

1. to determine the overall frequency of Inflammatory sacroiliitis among patients with Inflammatory bowel disease using magnetic resonance imaging 2. identify the association of sacroliitis in IBD patients clinical and laboratory markers

NCT ID: NCT05655533 Not yet recruiting - Clinical trials for Spondyloarthropathy and Sacroilitis

Added Value of Diffusion Weighted MRI in Evaluation of Sacroiliitis in Newly Diagnosed Patients of Spondyloarthropathy.

Start date: December 10, 2022
Phase:
Study type: Observational

Spondyloarthropathy encompasses a group of chronic immune-mediated rheumatic inflammatory diseases characterized by axial joint inflammation, peripheral arthritis, enthesitis, dactylitis and extra-articular features. Axial spondyloarthritis (SpA) has significant social and psychiatric impacts [2, 3] and affects quality-of-life (4-5).Early disease diagnosis is becoming more important as it will facilitate early therapeutic interventions (6). There's no "gold standard" feature for diagnosing axSpA. It's diagnosed through a combination of patient history, clinical examination, laboratory findings a and imaging tests, such as X-ray and MRI. Sacroiliitis is commonly the first manifestation and an important indicator of the diagnosis and classification of the the disease. (7) Radiographic sacroiliitis is a key criterion. However, sole reliance on radiographs is associated with significant diagnostic delay [8]. Magnetic Resonance Imaging (MRI) can detect axial inflammation before radiographic changes. Diffusion-weighted imaging (DWI) offers a new approach to assess inflammation. Recently several studies have shown that DWI is an effective tool in early diagnosis of axSpA (14-16). Furthermore, the ADC value may serve as a quantitative biomarker of disease activity, allowing monitoring and guiding treatment. (17-18)

NCT ID: NCT04329182 Not yet recruiting - Clinical trials for Active Sacroiliitis in Ankylosing Spondylitis

Color Doppler Ultrasonography in Evaluation of Active Sacroiliitis in Ankylosing Spondylitis

Start date: May 2020
Phase:
Study type: Observational

Evaluate the role of color Doppler ultrasonography (CDUS) in detection of active sacroiliitis in Ankylosing Spondylitis patients using MRI of the sacroiliac joints as a gold standard. Evaluate the relation of active sacroiliitis detected by color Doppler ultrasonography (CDUS) with disese activity in patients with ankylosing spondylitis